|
| |
vaxgen.com Pages on BioPortfolio:
BioPortfolio - VaxGen Incorporated
VaxGen Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/10762-VaxGen_Incorp...
|
BioPortfolio Biotechnology BioNews : live article
Jansen will lead a team of more than 40 VaxGen scientists and related personnel and will play a leading role in developing the company's existing ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - VaxGen, Inc. 1000 Marina Blvd
+1 650 624 10 00, Fax: +1 650 624 10 01, E-mail: jjermano@vaxgen. ... VaxGen, Inc. (VXGN) Raises $51.3 Million Through Sale Of Interest In Celltrion, ...
http://www.bioportfolio.com/search/VaxGen,_Inc._1000_Marina_...
|
BioPortfolio Biotechnology BioNews : live article
Sponsored by VaxGen, the trial is expected to enroll approximately 150 people. ... VaxGen, Inc. is a biopharmaceutical company engaged in the development, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - Biocorporate Search Incorporated
VaxGen were formed to continue development of AIDSVAX in partnership with Genentech. In connection with our formation, Genentech licensed to us the ...
http://www.bioportfolio.com/biocorporate/Incorporated-compan...
|
Biotechnology News Vaxgen nuvelo. brinkman. replidyn. transcept ...
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Biocorporate Search Bioterrorism 1
VaxGen Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and
...
http://www.bioportfolio.com/biocorporate/Bioterrorism%20%20-...
|
BioPortfolio Biotechnology BioNews : live article
In February, 2002, VaxGen and a group of South Korean investors formed Celltrion , ... VaxGen provided technical support and know-how, and the South Korean ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - VaxGen Inc. - Profile
VaxGen Inc. is a biopharmaceutical company focused on the development, ... Founded in 1995, VaxGen’s business strategy emphasizes the development and ...
http://www.bioportfolio.com/biocorporate/31617-VaxGen%25252B...
|
BioPortfolio Biotechnology BioNews : live article
The contract calls on VaxGen to provide 25 million doses of its recombinant ... For the remainder of the 5-year contract, VaxGen will be maintaining active ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
Results from other life science and pharmaceutical sites:
VaxGen, Inc
Development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease, with research and product
...
http://www.vaxgen.com/...
|
VaxGen and Raven biotechnologies Announce Signing of Definitive ...
Following the closing of the transaction, VaxGen stockholders will own approximately 51 percent of the combined company, on a pro forma basis, ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Pressroom ::: Next Generation Biodefense, Anthrax Vaccine ...
VaxGen, Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and
...
http://www.vaxgen.com/pressroom/index.html...
|
VaxGen Reports Phase I Clinical Trial Results Of Anthrax ...
BRISBANE, Calif., March 2 /PRNewswire-FirstCall/ -- VaxGen, Inc. today announced results of its Phase I trial of recombinant Protective Antigen anthrax ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1533692...
|
VaxGen to Present at CIBC World Markets Annual Biotechnology ...
About VaxGen VaxGen, Inc. is a biopharmaceutical company engaged in the development, manufacture and commercialization of biologic products for the ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
VaxGen, Inc. Receives Repayment in Full of Bridge Loan to Raven ...
VaxGen is a biopharmaceutical company based in South San Francisco, California. The company owns a state-of-the-art biopharmaceutical manufacturing facility ...
http://www.biospace.com/news_story.aspx?NewsEntityId=103823...
|
VaxGen and Raven Terminate Merger Agreement
In addition, VaxGen's Board has withdrawn from stockholder consideration the proposed 2008 Equity Incentive Plan, which is unnecessary in the absence of the
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
VaxGen, Inc. Provides Financial Update - News, Search Jobs, Events
27 /PRNewswire-FirstCall/ -- VaxGen, Inc. , a biopharmaceutical company, today provided a financial and operational update since the filing of its quarterly
...
http://www.biospace.com/news_story.aspx?NewsEntityId=108126...
|
VaxGen Announces Appointment of Randall Caudill as Board Chairman ...
"The selection of Randall as chairman reflects not only his valuable years of service to VaxGen but his wide understanding of the biotechnology industry, ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
VaxGen Sees Long Delay In Delivering Anthrax Va - News, Search ...
The modification's new requirements and the resulting delivery delays will increase the cost of contract performance for VaxGen and postpone revenues ...
http://www.biospace.com/news_story.aspx?NewsEntityId=18243...
|
|
